We highlight, in the heterogeneity of ovarian cancer, a characteristic “mitochondrial signature”, characterized by increased mitochondrial biogenesis and altered mitochondrial structure that could result from the cooperation of cAMP pathway and the SIRT3, OPA1, and PHB2 proteins. This evidence concerns the gene SIRT3 and ovarian carcinoma.